Health News-RSS Feeds

Reuters shed light on how U.S. and European airlines will benefit from pent-up demand for travel to China after its recent border reopening, but route approvals, fresh COVID-19 testing rules and not enough large aircrafts remain barriers to rising sales.

The post Reuters reveals Airlines face hurdles to cashing in on China re-opening appeared first on Reuters News Agency.

Reuters exclusively revealed that drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January. The increases are expected to come as the industry prepares for the Biden Administration’s Inflation Reduction Act, which lets the government negotiate prices directly for some drugs, starting in 2026.

The post Reuters reveals drugmakers to raise prices on at least 350 drugs in U.S. in January appeared first on Reuters News Agency.

Reuters exclusively reported that, as COVID-19 infections surge in China, the U.S. Centers for Disease Control and Prevention is considering sampling wastewater taken from international aircrafts to track any emerging new variants.

The post Reuters reveals U.S. considers airline wastewater testing as COVID surges in China appeared first on Reuters News Agency.

Reuters shed light on how China is sticking with a strict COVID-19 containment strategy nearly three years into the pandemic, potentially disappointing investors hoping for a quick reopening, although authorities are making ongoing if modest tweaks to managing the virus. Numerous analysts and experts say China is unlikely to begin significant easing of its outlier zero-COVID approach, which is squeezing the economy and fuelling widespread frustration, before an annual parliamentary session in March — at the earliest.

The post Reuters reveals for China’s COVID policy, change comes in small increments appeared first on Reuters News Agency.